Evidence map›Paper›PMID 25403476›Full record

ArticleBMJ (Clinical research ed.)2014

Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.

Maarten J G Leening, Bart S Ferket, Ewout W Steyerberg, Maryam Kavousi, Jaap W Deckers, Daan Nieboer, Jan Heeringa, Marileen L P Portegies, Albert Hofman, M Arfan Ikram and 5 more

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maarten J G LeeningDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Cardiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Epidemiology, Harvard School of Public Health, Boston, MA, US.
Bart S FerketDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Institute of Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, US.
Ewout W SteyerbergDepartment of Public Health, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Maryam KavousiDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Jaap W DeckersDepartment of Cardiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Daan NieboerDepartment of Public Health, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Jan HeeringaDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Marileen L P PortegiesDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Neurology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Albert HofmanDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Epidemiology, Harvard School of Public Health, Boston, MA, US.
M Arfan IkramDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Neurology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
M G Myriam HuninkDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, US.
Oscar H FrancoDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Bruno H StrickerDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Department of Internal Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands Inspectorate for Health Care, The Hague, Netherlands b.stricker@erasmusmc.nl.
Jacqueline C M WittemanDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.
Jolien W Roos-HesselinkDepartment of Cardiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate differences in first manifestations of cardiovascular disease between men and women in a competing risks framework.

designProspective population based cohort study.

settingPeople living in the community in Rotterdam, the Netherlands.

participants8419 participants (60.9% women) aged ≥ 55 and free from cardiovascular disease at baseline.

main outcome measuresFirst diagnosis of coronary heart disease (myocardial infarction, revascularisation, and coronary death), cerebrovascular disease (stroke, transient ischaemic attack, and carotid revascularisation), heart failure, or other cardiovascular death; or death from non-cardiovascular causes. Data were used to calculate lifetime risks of cardiovascular disease and its first incident manifestations adjusted for competing non-cardiovascular death.

resultsDuring follow-up of up to 20.1 years, 2888 participants developed cardiovascular disease (826 coronary heart disease, 1198 cerebrovascular disease, 762 heart failure, and 102 other cardiovascular death). At age 55, overall lifetime risks of cardiovascular disease were 67.1% (95% confidence interval 64.7% to 69.5%) for men and 66.4% (64.2% to 68.7%) for women. Lifetime risks of first incident manifestations of cardiovascular disease in men were 27.2% (24.1% to 30.3%) for coronary heart disease, 22.8% (20.4% to 25.1%) for cerebrovascular disease, 14.9% (13.3% to 16.6%) for heart failure, and 2.3% (1.6% to 2.9%) for other deaths from cardiovascular disease. For women the figures were 16.9% (13.5% to 20.4%), 29.8% (27.7% to 31.9%), 17.5% (15.9% to 19.2%), and 2.1% (1.6% to 2.7%), respectively. Differences in the number of events that developed over the lifespan in women compared with men (per 1000) were -7 for any cardiovascular disease, -102 for coronary heart disease, 70 for cerebrovascular disease, 26 for heart failure, and -1 for other cardiovascular death; all outcomes manifested at a higher age in women. Patterns were similar when analyses were restricted to hard atherosclerotic cardiovascular disease outcomes, but absolute risk differences between men and women were attenuated for both coronary heart disease and stroke.

conclusionsAt age 55, though men and women have similar lifetime risks of cardiovascular disease, there are considerable differences in the first manifestation. Men are more likely to develop coronary heart disease as a first event, while women are more likely to have cerebrovascular disease or heart failure as their first event, although these manifestations appear most often at older ages.

Indexed as

Cardiovascular DiseasesCerebrovascular DisordersCohort StudiesCoronary Artery DiseaseCoronary DiseaseFemaleHeart FailureHumansIncidenceMaleMiddle AgedMyocardial InfarctionRegression AnalysisSex Factors

Identifiers

PMID25403476
PMCPMC4233917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.